Chemotherapy of Metastatic Non-Small Cell Lung Cancer Lacking Activating Mutations
There are presented modern therapeutic algorithms for treatment of non-small cell lung cancer lacking activating mutations. Gemcitabine is a drug of choice during squamous cell cancer, whereas pemetrexed combined with bevacizumab (in case the former was used during induction phase) are indicated during non-squamous cell carcinoma.